
IOZK (Immun-Onkologisches Zentrum Köln) is an outpatient center for cancer immunotherapy in Cologne, Germany. Its program combines the IO-VAC dendritic cell vaccine, virotherapy and hyperthermia. The center says it has about 60 employees.
IOZK immunotherapy adds to standard treatment and does not replace it. The center states that it cannot give efficacy statistics, because it runs no comparative clinical trials.
We coordinate treatment at IOZK for international patients. Our coordination is free: you pay the center directly.
IOZK Germany is the Immun-Onkologisches Zentrum Köln, an outpatient center for cancer immunotherapy in Cologne. Its work is built around IO-VAC, a vaccine made from the patient's own immune cells. It also uses virotherapy and heat treatment (hyperthermia). The therapy is meant to add to standard cancer treatment. It does not replace surgery, chemotherapy or radiation.
The center combines several methods for each patient:
The center says it holds a manufacturing license under Section 13 of the German Medicines Act (AMG) for the dendritic cell vaccine. Such a license covers how the vaccine is made. It does not show that the treatment works. Each step is explained on the center's treatment process page. Our overview of immunotherapy in Israel and Germany compares the center with other programs.
The center says immunotherapy can, in principle, be used for any malignant tumor. Its effectiveness has not been studied equally for all cancers. The IOZK FAQ says immunotherapy has been evaluated mainly in cancers with no highly effective standard treatment. Examples are malignant melanoma and glioblastoma, a fast-growing brain tumor. That statement is about immunotherapy as a field, not about results of the IOZK method.
For glioblastoma, the center names Dr Stefaan Van Gool as its physician in charge of neuro-oncology (the care of brain tumors). If you are comparing options for a brain tumor, see our guide to brain tumor treatment abroad. For skin cancers such as melanoma or lung cancer, we describe standard treatment at other clinics in Germany.
The center employs about 60 people. The team page on iozk.de names these specialists:
All
Oncology
The IOZK therapy costs page gives these guide prices. Laboratory tests before treatment cost 6,800 to 8,500 EUR. One IO-VAC vaccination cycle costs 23,000 to 26,000 EUR, and at least two cycles are required. A five-day treatment unit, used alongside chemotherapy or as maintenance after the vaccination cycles, costs 6,000 to 11,000 EUR. Both prices exclude any additional antibody therapy. The amounts do not include individual medications such as infusions. The center's FAQ page gives different ranges (3,500 to 5,000 EUR for the tests and 23,000 to 28,000 EUR per cycle), so ask the center for a written quote for your case. The final price depends on your case and your plan.
| Laboratory tests before treatment | 6 800 – 8 500 € | Enquire price |
| IO-VAC vaccination cycle (at least two cycles are required) | 23 000 – 26 000 € | Enquire price |
| Five-day treatment unit (alongside chemotherapy or as maintenance) | 6 000 – 11 000 € | Enquire price |
Prices on this page were last reviewed on November 6, 2026. Get the current price for your case
We first send your diagnosis, scans and reports to the center. It then describes these steps:
Treatment is outpatient, so you stay in a hotel nearby. The center advises contacting it before a planned operation. Then tumor tissue from the operation can be used to make the vaccine. Immunotherapy is not on the list of services paid by statutory health insurance in Germany. Private insurers may reimburse it, depending on the contract. In some cases, costs are covered on application. According to the center, a common side effect is flu-like symptoms the day after the first dose of the virus, as described in its FAQ.
The Immuno-Oncological Center IOZK Cologne is at Hohenstaufenring 30–32, in the city center. The center lists tram lines 16 and 18 to Barbarossaplatz. From the main station it is about 15 minutes on foot. There is an underground car park at Hohenstaufenring 29–37. We help you book the airport transfer and a hotel close to the center.
This page shows five patient reviews, all rated 5 out of 5. One of them, dated 2024, is from the wife of a patient with stage 4 brain cancer. They are personal opinions. We do not treat them as proof of results, and the outcome differs from patient to patient. Reviews mention:
Immunotherapy does not replace chemotherapy or radiation. The center itself says in its FAQ that it cannot give statistics on the efficacy of its immunotherapy, because it runs no comparative clinical trials. The center's general schedule is about five weeks, and statutory insurance does not pay for it.
If your cancer has a standard treatment that works well, we suggest you start with that. Read about radiation therapy in Israel, Germany and Turkey to compare. Then ask your oncologist whether adding it makes sense for you. You can find oncologists in Germany in our catalog, and more options in the oncology specialty.
Medically reviewed by Erika Igonina, medical editor of Experts Medical. Updated November 6, 2026





we will contact you within 15 minutes
The IOZK Immun-Onkologisches Zentrum Köln is at Hohenstaufenring 30–32, 50674 Cologne, Germany. It works as an outpatient center. Patients stay in hotels nearby, and we help with the booking.
Send your diagnosis, scans and medical reports, including earlier treatment. At the initial consultation, the doctors go through your history and findings. We pass your records to the center and can tell you if something is missing.
Yes, and the center advises it. If your own tumor tissue can be used to make the vaccine, that helps the treatment. Write to us before the operation date, and we will pass your request on.
They mention respect, attention and a contact person patients trust. They are personal opinions and not evidence of results.
The center accepts patients with brain tumors and names Dr Stefaan Van Gool as its physician in charge of neuro-oncology. Its FAQ names glioblastoma, together with malignant melanoma, among the cancers where immunotherapy in general has mostly been evaluated. The center also says it cannot give statistics on the efficacy of its own method. Discuss this option with your neuro-oncologist as an addition to standard treatment.
The center’s general schedule is two vaccination cycles over about five weeks. On its therapy costs page the center gives guide prices of 6,800 to 8,500 EUR for the laboratory tests before treatment and 23,000 to 26,000 EUR for one IO-VAC vaccination cycle, and at least two cycles are required. These amounts do not include individual medications. The center’s own FAQ page gives different ranges (3,500 to 5,000 EUR for the tests and 23,000 to 28,000 EUR per cycle), so ask for a written quote for your case.
No. The center presents its immunotherapy as an addition to standard treatment, such as surgery, chemotherapy and radiation. Statutory health insurance does not pay for it. Your oncologist should decide with you whether to add it.